Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery: A Randomized Controlled Trial

NCT07816068 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT07816068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07816068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Remimazolam on Postoperative Cognitive Dysfunction and Neuroinflammatory Biomarkers in Patients Undergoing Aortic Arch Surgery: A Randomized Controlled Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
November 30, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm of the proximal arch, aortic aneurysms arch, aortic arch disease, postoperative delirium, postoperative delirium (pod), postoperative delirium and postoperative cognitive decline